Education
About Us
Working with TipRanks
Follow Us
Acrux Limited (AU:ACR)
:ACR
ACR Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.09
Previous CloseN/A
Volume88.57K
Average Volume (3M)295.08K
Market Cap
AU$8.96M
Enterprise ValueAU$20.76M
Total Cash (Recent Filing)AU$19.04M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-0.24
Next Earnings
Aug 22, 2025EPS EstimateN/A
Last Dividend Ex-Date
Aug 18, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding407,315,200
10 Day Avg. Volume195,747
30 Day Avg. Volume295,083
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)9.25
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Acrux Limited News
PremiumCompany Announcements
Acrux Limited Announces Registry Office Relocation
PremiumCompany Announcements
Acrux Limited Announces Director’s Acquisition of Options
PremiumCompany Announcements
Acrux Limited Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Acrux Secures $1.73 Million Advance on R&D Tax Incentive
PremiumCompany Announcements
Acrux Limited Issues New Director Placement Shares
PremiumCompany Announcements
Acrux Limited Announces Quotation of New Securities on ASXPremiumCompany Announcements
Acrux Limited Highlights Future Prospects in Topical Pharmaceuticals
PremiumCompany Announcements
Acrux Limited Announces Investor Webinar to Discuss Half-Year Results---
Options Prices
Currently, No data available
---
Ownership Overview
4.79% Insiders
―
Mutual Funds
― Other Institutional Investors
95.21% Public Companies and
Individual Investors
ACR FAQ
What was Acrux Limited’s price range in the past 12 months?
Acrux Limited lowest share price was AU$0.02 and its highest was AU$0.09 in the past 12 months.
What is Acrux Limited’s market cap?
Acrux Limited’s market cap is AU$8.96M.
When is Acrux Limited’s upcoming earnings report date?
Acrux Limited’s upcoming earnings report date is Aug 22, 2025 which is in 135 days.
How were Acrux Limited’s earnings last quarter?
Acrux Limited released its earnings results on Feb 25, 2025. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
Is Acrux Limited overvalued?
According to Wall Street analysts Acrux Limited’s price is currently Overvalued.
Does Acrux Limited pay dividends?
Acrux Limited pays a Notavailable dividend of AU$0.059 which represents an annual dividend yield of N/A. See more information on Acrux Limited dividends here
What is Acrux Limited’s EPS estimate?
Acrux Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acrux Limited have?
Acrux Limited has 407,315,200 shares outstanding.
What happened to Acrux Limited’s price movement after its last earnings report?
Acrux Limited reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -17.241%.
Which hedge fund is a major shareholder of Acrux Limited?
Currently, no hedge funds are holding shares in AU:ACR
---
Acrux Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ACR Sentiment 70%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $90.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
21.21%
12-Months-Change
Fundamentals
Return on Equity
-132.58%
Trailing 12-Months
Asset Growth
-41.17%
Trailing 12-Months
Company Description
Acrux Limited
Acrux Limited (ACR) is an Australian-based pharmaceutical company specializing in the development and commercialization of topical drug delivery systems. The company focuses on creating innovative solutions for delivering drugs through the skin, providing alternative options for patients and healthcare providers. Acrux's core products include transdermal patches and topical solutions designed to enhance therapeutic outcomes across various medical conditions.
---
Technical Analysis
---